1. Home
  2. MNKD vs DQ Comparison

MNKD vs DQ Comparison

Compare MNKD & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • DQ
  • Stock Information
  • Founded
  • MNKD 1991
  • DQ 2006
  • Country
  • MNKD United States
  • DQ China
  • Employees
  • MNKD N/A
  • DQ N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • DQ Semiconductors
  • Sector
  • MNKD Health Care
  • DQ Technology
  • Exchange
  • MNKD Nasdaq
  • DQ Nasdaq
  • Market Cap
  • MNKD 1.7B
  • DQ 2.0B
  • IPO Year
  • MNKD 2004
  • DQ 2010
  • Fundamental
  • Price
  • MNKD $5.00
  • DQ $34.71
  • Analyst Decision
  • MNKD Buy
  • DQ Buy
  • Analyst Count
  • MNKD 6
  • DQ 4
  • Target Price
  • MNKD $10.25
  • DQ $32.50
  • AVG Volume (30 Days)
  • MNKD 4.3M
  • DQ 1.4M
  • Earning Date
  • MNKD 11-05-2025
  • DQ 10-27-2025
  • Dividend Yield
  • MNKD N/A
  • DQ N/A
  • EPS Growth
  • MNKD 23.47
  • DQ N/A
  • EPS
  • MNKD 0.10
  • DQ N/A
  • Revenue
  • MNKD $313,787,000.00
  • DQ $639,063,000.00
  • Revenue This Year
  • MNKD $14.78
  • DQ N/A
  • Revenue Next Year
  • MNKD $19.36
  • DQ $56.95
  • P/E Ratio
  • MNKD $50.82
  • DQ N/A
  • Revenue Growth
  • MNKD 17.43
  • DQ N/A
  • 52 Week Low
  • MNKD $3.38
  • DQ $12.41
  • 52 Week High
  • MNKD $7.07
  • DQ $36.59
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 39.71
  • DQ 61.81
  • Support Level
  • MNKD $4.95
  • DQ $30.26
  • Resistance Level
  • MNKD $6.24
  • DQ $36.59
  • Average True Range (ATR)
  • MNKD 0.29
  • DQ 2.55
  • MACD
  • MNKD -0.08
  • DQ 0.21
  • Stochastic Oscillator
  • MNKD 4.26
  • DQ 77.35

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: